Loading organizations...
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| Oct 1, 2020 | ILIAS Biologics | $20.6M Series B | — | Daedeok Venture Partners, Daishin Private Equity, Dev Sisters Ventures, Genie Asset Management, Hanyang Securities/Yeolim Partners, HB Investment, Kiwoom Securities, Meritz Securities, Timefolio Asset Management |